TSH Biopharm Corporation Limited (TPEX:8432)
55.00
-0.40 (-0.72%)
Oct 20, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 2.11 billion as of October 20, 2026. It is the 28,202nd most valuable company in the world and the 1,613th biggest in Taiwan. Its market cap has increased by 1.10% in one year.
Market Cap
2.11B
Enterprise Value
1.33B
Revenue
1.40B
Global Rank
Country Rank
#1,613 Taiwan
PE Ratio
12.64
ChartMarket Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 2.11B, an increase of 7.63%. That is a compound annual growth rate of 0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 2.11B | -5.98% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 3.98B |
| Easywell Biomedicals | 3.52B |
| Maywufa Company | 2.79B |
| Allied Biotech | 2.66B |
| Merdury Biopharmaceutical | 2.63B |
| PhytoHealth | 2.25B |
| Johnson Chemical Pharmaceutical Works | 2.13B |
| Tien Liang BioTech | 1.83B |